Adviser to the Prime Minister for Health Affairs and the head of the coronavirus file in Jordan, Dr. Adel Al-Belbisi, said Saturday that he expects the coronavirus mutant to be prevalent for the next month, due to its rapid spread. 

He explained that the epidemiological curve decreased by five percent in the last week, and the number of positive tests have stabilized.

Regarding the new wave of the coronavirus, he said "it is likely that the Kingdom will witness an Omicron wave, in light of its global spread and its entry into Jordan," explaining that Omicron is less virulent than the Delta mutant.

He further indicated that 15 percent of the cases recorded in the last week belong to the Omicron mutant.

Al-Belbisi stressed the importance of the third dose of the coronavirus vaccine in raising immunity against the virus, especially the rapidly spreading mutated Omicron.

He added, "More than 300,000 people in the Kingdom received the third dose, and 10 percent of the target group."

The target group is everyone who received the second dose three months ago, he explained. 

On treatments for the coronavirus, he explained that Jordan is negotiating with four international pharmaceutical companies to provide several treatments, including "molnopiravir," stressing that negotiations are still ongoing to determine the most effective treatments and purchase.